Barclays Cuts Clorox (NYSE:CLX) Price Target to $112.00

Clorox (NYSE:CLX) had its target price decreased by Barclays from $118.00 to $112.00 in a report issued on Tuesday morning, MarketBeat reports. Barclays currently has an underweight rating on the stock.

CLX has been the subject of several other research reports. UBS Group cut their price objective on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a report on Thursday, July 17th. Citigroup reissued a “neutral” rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Morgan Stanley decreased their price target on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research report on Monday, September 8th. Finally, Jefferies Financial Group cut their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a report on Thursday, June 26th. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average target price of $134.08.

Clorox Stock Performance

Shares of CLX opened at $122.25 on Tuesday. The stock’s 50-day simple moving average is $122.96 and its 200 day simple moving average is $129.78. Clorox has a 52-week low of $116.53 and a 52-week high of $171.37. The stock has a market capitalization of $14.95 billion, a price-to-earnings ratio of 18.75, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. Clorox’s revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts forecast that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. Clorox’s payout ratio is presently 76.07%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On Clorox

Institutional investors have recently bought and sold shares of the stock. Raymond James Financial Inc. boosted its holdings in shares of Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after buying an additional 36,352 shares in the last quarter. OneDigital Investment Advisors LLC bought a new stake in Clorox during the first quarter worth about $247,000. Brown Miller Wealth Management LLC purchased a new stake in Clorox in the first quarter worth about $399,000. Roman Butler Fullerton & Co. bought a new position in shares of Clorox during the first quarter valued at approximately $400,000. Finally, Wedge Capital Management L L P NC increased its stake in shares of Clorox by 33.5% during the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock valued at $4,198,000 after purchasing an additional 7,159 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.